

19 Oct 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/gujarat-themis-biosyn-doubles-fermentation-production-capacity-at-vapi-18034

19 Oct 2019
// BIOSPACE
https://www.biospace.com/article/releases/redhill-biopharma-announces-36-million-strategic-investment-by-cosmo-pharmaceuticals-and-u-s-rights-to-approved-travelers-diarrhea-drug-aemcolo/?s=95

05 Feb 2019
// Derek Lowe SCIENCE MAG BLOG
https://blogs.sciencemag.org/pipeline/archives/2019/02/04/2018-drug-approvals-a-closer-look?r3f_986=https://www.google.com/

21 Nov 2018
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/marketing/cosmo-to-give-bausch-health-sales-a-run-latest-fda-nod-for-xifaxan-rival

17 Nov 2018
// FDA
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626121.htm?utm_campaign=FDA%20approves%20new%20treatment%20of%20travelers%E2%80%99%20diarrhea%20caused%20by%20noninvasive%20strains%20of%20Escherichia%20coli&utm_medium=email&utm_source=Eloqua

21 May 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-accepts-new-drug-application-for-aemcolo-rifamycin-sv-mmx-and-sets-pdufa-date-for-november-16-2018-300651877.html